Australian healthcare AI startup Heidi Health, co-founded by Waleed Mussa, Dr. Thomas Kelly, and Yu Liu, has secured a monumental $65 million in a Series B funding round, signaling strong investor confidence in the company’s mission to revolutionize medical administration.
Based in Melbourne, Heidi aims to alleviate the administrative burden on clinicians by using artificial intelligence to automate tasks like note-taking and documentation, allowing doctors to focus more on patient care.
Heidi’s Rapid Growth and Investor Backing
This latest funding, led by Point72 Private Investments, a firm backed by billionaire Steve Cohen, values the company at an impressive $465 million, marking it as one of Australia’s fastest-growing health tech startups.
Additional support came from existing investors such as Blackbird, Headline, and LocalGlobe, bringing Heidi’s total funding to nearly $100 million since its inception six years ago.
Addressing a Global Healthcare Crisis
The technology comes at a critical time as healthcare systems worldwide, including Australia, grapple with workforce shortages and clinician burnout due to overwhelming administrative workloads.
By automating repetitive tasks, Heidi’s AI tools have already saved clinicians millions of hours, potentially increasing healthcare capacity and improving patient outcomes.
Expansion Plans and Future Vision
With the fresh capital, Heidi plans to expand its presence internationally, targeting markets like Hong Kong and Singapore, with intentions to build local teams of 15 to 20 people in each location by next year.
The company envisions becoming an AI care partner for every clinician, further integrating its technology to streamline operations in hospitals and clinics globally.
A Look Back at Heidi’s Journey
Founded with a mission to support overworked medical professionals, Heidi has rapidly evolved from a niche startup to a key player in health tech, following a $25.7 million Series A top-up just seven months prior to this round.
Its growth reflects a broader trend of AI adoption in healthcare, where technology is increasingly seen as a solution to systemic inefficiencies.
As Heidi continues to scale, its impact could redefine how healthcare providers manage time and resources, potentially setting a new standard for medical administration worldwide.
Industry watchers are eager to see if Heidi can maintain this momentum, as its success may inspire further innovation in the intersection of AI and healthcare.
Andrew Lee
